KBL Merger Corp. IV (KBLM), filed a preliminary proxy this afternoon proposing to extend their current completion deadline of December 9, 2019 to April 9, 2020. KBLM announced they had signed a definitive agreement with CannBioRx, back on July 26, 2019, three months ago, but this new extension will give them an additional four months to close their combination.
As for the particulars, KBLM will be contributing $0.02 each month to the trust for shareholders that do not redeem at the extension vote, a slight reduction from the $0.0225 that KBLM previously offered to extend. Additionally, KBLM is requiring shareholders that wish to redeem MUST vote at this extension. That means any redeemers MUST be a shareholder of Record with the Record Date being November 8th.
So what does all this mean. For one, the fact that KBLM is requiring shareholders to vote typically indicates they are trying to reduce the amount of cash in trust. Meaning, they either have too much cash for the transaction to make sense or, they are trying to eliminate SPAC shareholders so they can replace them with an equity investor, a PIPE. However, whether that is done at a price substantially below trust value or at/near trust value remains to be seen. Either way, expect a significant number of redemptions at this vote due to the reduced contribution to trust and the required vote.
McKinley Acquisition Corporation (NASDAQ:MKLYU) has filed for a $150 million SPAC to hunt for an innovative target company with an experienced financial team that has dabbled in SPACs before. The new SPAC is offering investors one right to a 1/10 share in each unit with no overfunding of the trust, but it could provide a...
At the SPAC of Dawn The rain of SPACs has continued with four expected to make their debuts during today’s trading sessions after pricing their IPOs overnight. The largest of these, EQV Ventures II (NASDAQ:EVACU), even managed an upsize, making it the largest SPAC IPO since Ares II (NYSE:AACT) pulled together $450 million in 2023....
EQV Ventures II (NASDAQ:EVACU) announced the pricing of its upsized $420 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “EVACU”, Wednesday, July 2, 2025. The new SPAC plans to merge with an energy target involved in upstream exploration or production. EQV II’s management team is led by...
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....